Close



Feb 28, 2024 06:30AM
Nov 1, 2023 06:30AM
Oct 18, 2023 08:07AM
Oct 18, 2023 08:00AM
Sep 18, 2023 07:00AM
Sep 18, 2023 07:00AM
Aug 2, 2023 06:30AM G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights
May 3, 2023 06:30AM
Mar 1, 2023 06:30AM
Mar 1, 2023 06:30AM
Feb 9, 2023 08:00AM
Jan 9, 2023 06:31AM
Jan 9, 2023 06:30AM
Nov 2, 2022 06:30AM G1 Therapeutics Provides Third Quarter 2022 Financial Results and Operational Highlights
Nov 2, 2022 06:30AM
Oct 10, 2022 06:30AM
Aug 3, 2022 06:30AM
Jul 25, 2022 06:31AM
Jul 25, 2022 06:30AM
Jul 13, 2022 10:16AM
Jul 13, 2022 10:15AM COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease the Incidence of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer (ES-
Jul 13, 2022 10:15AM
Jun 13, 2022 07:00AM
May 20, 2022 10:30AM
May 4, 2022 06:30AM
Feb 23, 2022 06:30AM
Dec 16, 2021 06:02AM
Dec 16, 2021 06:00AM G1 Therapeutics Announces Expansion of COSELA™ (Trilaciclib) Sales Force
Nov 11, 2021 07:26PM
Nov 3, 2021 06:30AM
Oct 7, 2021 08:00AM
Oct 1, 2021 07:45AM
Sep 15, 2021 06:46AM
Sep 15, 2021 06:45AM
Aug 4, 2021 04:01PM G1 Therapeutics Provides Second Quarter 2021 Financial Results and Operational Highlights
Aug 4, 2021 08:00AM
Jul 19, 2021 09:21AM
Jul 19, 2021 09:20AM
Jun 4, 2021 09:01AM
May 17, 2021 07:00AM
May 5, 2021 04:01PM
Apr 26, 2021 09:44AM G1 Therapeutics (GTHX) Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA™ (trilaciclib) in Clinical Lung Cancer
Apr 26, 2021 09:41AM
Apr 1, 2021 07:30AM
Mar 25, 2021 06:52AM
Mar 25, 2021 06:50AM
Mar 2, 2021 07:00AM
Mar 2, 2021 06:59AM
Feb 24, 2021 04:01PM G1 Therapeutics Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Feb 16, 2021 09:28AM

251,613 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All